TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
IBIO

iBio, Inc.

Healthcare · Biotechnology

1.20$ +0.9% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

iBio, Inc. (IBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 99 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IBIO
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
12 52 36 43 31 94 147 99 41 29 23 99
10 24 8.6 16 4.8 62 105 45 26 16 9.7 92
9.5 23 8.1 16 4.4 55 77 23 7.3 14 8.6 56
9.5 23 8.1 16 4.4 55 97 34 7.3 14 8.6 88
0.4 0.6 0.2 0.1 0.1 5.6 5.5 6.1 0.2 0.7 0.1 1.1
0.2 0.0 0.0 0.0 0.0 0.8 0.0 3.9 21 – – –
0.0 26 26 25 24 3.7 35 42 7.6 – – –
0.0 0.0 0.0 0.0 – – – – – – – –
2.4 2.1 1.8 1.6 1.4 1.1 1.0 4.9 5.4 5.4 6.8 1.8
1.3 28 27 27 28 38 38 36 26 7.4 8.3 13
1.3 2.3 2.0 2.0 3.5 5.2 6.6 30 22 3.8 6.1 12
– 0.2 0.2 0.2 0.2 0.6 1.0 22 14 1.0 1.3 0.5
1.0 0.7 0.3 0.8 1.0 1.8 2.3 4.3 1.8 0.4 2.2 4.4
0.0 25 25 25 – 0.3 – – – 0.8 – –
11 9.9 8.9 16 2.5 57 109 63 15 21 15 86
-48 -58 -72 -88 -106 -150 -174 -224 -289 -314 -332 -365
0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.6 3.8 10 104

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?